|
Author: Mazen El-Hammadi, Nisrine Awad
Keywords: dissolution rate,liquisolid compacts,loratadine,pH variations,solubility
Summary: the Use of Liquisolid Compacts Technique to Minimize the Influence of pH Variations on Loratadine R dissolution rate, liquisolid compacts technique can be suggested as a promising solution. loratadine using liquisolid compacts technique may reduce the effect of pH variation on the drug di
AAPS PharmSciTech; Vol. 13 Number 1, Mar 2012;Published Date:02/29/2012; DOI: 10.1208/s12249-011-9719-6
|
|
Author: Enas A. Mahmoud, Ehab R. Bendas, Magdy I. Mohamed
Keywords: carvedilol,dry nanoemulsion,granulated silicon dioxide,liquisolid tablets,SEDDS,SNEDDS,SNET
Summary: improved the physical properties of liquisolid powders containing SNEDDS. carvedilol; dry nanoemulsion; granulated silicon dioxide; liquisolid tablets; SEDDS; compacts, is used to transfer liquid medication into acceptably
AAPS PharmSciTech; Vol. 10 Number 1, Mar 2009;Published Date:02/28/2009; DOI: 10.1208/s12249-009-9192-7
|
|
Author: Yogesh Rane, Rajshree Mashru, Mayur Sankalia, Jolly Sankalia
Keywords: Solid dispersion,factorial design,similarity factor,mean dissolution time,carbamazepine,multiple linear regression,simulated gastric fluid
Summary: such as liquisolid, in which drug in solution state or dis-
AAPS PharmSciTech; Vol. 8 Number 2, Jun 2007;Published Date:05/31/2007; DOI: 10.1208/pt0802027
|
|
Author: Magdy M. Ibrahim, Mohamed EL-Nabarawi, Doaa Ahmed El-Setouhy, Montasir A. Fadlalla
Keywords: chewable tablets,etodolac,hydroxypropyl-β-cyclodextrin,inutec,in vivo absorption study,solid dispersion
Summary: drug with additives (6), making liquisolid formulations (7)
AAPS PharmSciTech; Vol. 11 Number 4, Dec 2010;Published Date:11/30/2010; DOI: 10.1208/s12249-010-9548-z
|
|
Author: Tejal J. Shah, Avani F. Amin, Jolly R. Parikh, Rajesh H. Parikh
Keywords: Solid dispersion,factorial design,poloxamer,poorly water-soluble drug
Summary: AAPS PharmSciTech 2007; 8 (2) Article 29 (http://www.aapspharmscitech.org).
Process Optimization and Characterization of Poloxamer Solid Dispersions of a
Poorly Water-soluble Drug
Submitted: April 1,
AAPS PharmSciTech; Vol. 8 Number 2, Jun 2007;Published Date:05/31/2007; DOI: 10.1208/pt0802029
|
|
Author: Vivian Gray, Gregg Kelly, Min Xia, Chris Butler, Saji Thomas, Stephen Mayock
Keywords: biorelevant methods,dissolution,in vitro–in vivo correlation,quality by design,variability
Summary: Pharmaceutical Research, Vol. 26, No. 6, June 2009 (# 2009)
DOI: 10.1007/s11095-008-9822-x
Expert Review
The Science of USP 1 and 2 Dissolution: Present Challenges
and Future Relevance
Vivian Gray,1,7
Pharmaceutical Research; Vol. 26 Number 6, Jun 2009;Published Date:05/31/2009; DOI: 10.1007/s11095-008-9822-x
|
|
Author: Mark Sacchetti, Elham Nejati
Keywords: drug solubility,lipid dosage form
Summary: AAPS PharmSciTech, Vol. 13, No. 4, December 2012 ( # 2012) DOI: 10.1208/s12249-012-9830-3 Research Article Prediction of Drug Solubility in Lipid Mixtures from the Individual Ingredients Mark Sacchetti1,3
AAPS PharmSciTech; Vol. 13 Number 4, Dec 2012;Published Date:11/30/2012; DOI: 10.1208/s12249-012-9830-3
|
|
Author: Howida Kamal Ibrahim, Doaa A. El-Setouhy
Keywords: 33 full factorial design,freeze-drying technique,in vivo study,orodispersible tablets,valsartan
Summary: AAPS PharmSciTech, Vol. 11, No. 1, March 2010 ( # 2010)
DOI: 10.1208/s12249-009-9354-7
Research Article
Valsartan Orodispersible Tablets: Formulation, In vitro/In vivo Characterization
Howida Kamal
AAPS PharmSciTech; Vol. 11 Number 1, Mar 2010;Published Date:02/28/2010; DOI: 10.1208/s12249-009-9354-7
|